Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × ispinesib × Clear all

NCT00097409 2010-10-04

Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms, Recurrence